Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

A Pilot Study Suggesting Several Benefits of Alpha Lipoic Acid in Patients with Diabetes

Author(s): Athyros G. Vasilios*, Sfikas George, Koumaras Charalambos and Athyrou Valasia

Volume 21, Issue 2, 2023

Published on: 08 March, 2023

Page: [143 - 144] Pages: 2

DOI: 10.2174/1570161121666230210100920

Price: $65

« Previous Next »
[1]
Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17(10): 888-95.
[http://dx.doi.org/10.1016/S0899-9007(01)00658-X] [PMID: 11684397]
[2]
Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2022; 29(1): 5-115.
[http://dx.doi.org/10.1093/eurjpc/zwab154] [PMID: 34558602]
[3]
Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin Drug Saf 2015; 14(6): 935-55.
[http://dx.doi.org/10.1517/14740338.2015.1039980] [PMID: 25907232]
[4]
Papanas N, Ziegler D. Efficacy of α-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother 2014; 15(18): 2721-31.
[http://dx.doi.org/10.1517/14656566.2014.972935] [PMID: 25381809]
[5]
Li J, Luo Y, Xu Y, et al. Risk factors of peripheral arterial disease and relationship between low ankle - brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes. Circ J 2007; 71(3): 377-81.
[http://dx.doi.org/10.1253/circj.71.377] [PMID: 17322639]
[6]
Bytyçi I, Penson PE, Mikhailidis DP, et al. Prevalence of statin intolerance: A meta-analysis. Eur Heart J 2022; 43(34): 3213-23.
[http://dx.doi.org/10.1093/eurheartj/ehac015] [PMID: 35169843]
[7]
Athyros VG, Tziomalos K, Kakafika AI, Koumaras H, Karagiannis A, Mikhailidis DP. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. Am J Cardiol 2008; 101(4): 483-5.
[http://dx.doi.org/10.1016/j.amjcard.2007.09.096] [PMID: 18312762]
[8]
Vincent HK, Bourguignon CM, Vincent KR, Taylor AG. Effects of alpha-lipoic acid supplementation in peripheral arterial disease: A pilot study. J Altern Complement Med 2007; 13(5): 577-84.
[http://dx.doi.org/10.1089/acm.2007.6177] [PMID: 17604563]
[9]
El-Hattab AW, Zarante AM, Almannai M, Scaglia F. Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab 2017; 122(3): 1-9.
[http://dx.doi.org/10.1016/j.ymgme.2017.09.009] [PMID: 28943110]
[10]
Solmonson A, DeBerardinis RJ. Lipoic acid metabolism and mitochondrial redox regulation. J Biol Chem 2018; 293(20): 7522-30.
[http://dx.doi.org/10.1074/jbc.TM117.000259] [PMID: 29191830]
[11]
Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: Impact on statin therapy-european atherosclerosis society consensus panel statement on assessment, aetiology and management. Eur Heart J 2015; 36(17): 1012-22.
[http://dx.doi.org/10.1093/eurheartj/ehv043] [PMID: 25694464]
[12]
Derosa G, D’Angelo A, Preti P, Maffioli P. Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention. Drug Des Devel Ther 2020; 14: 5367-74.
[http://dx.doi.org/10.2147/DDDT.S280802] [PMID: 33299302]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy